New Delhi [India], February 21 (ANI): Pune-based Serum Institute of India CEO Adar Poonawalla requested the countries to 'be patient' as they await the Covishield supplies, adding that SII is trying to maintain a balance between the needs of India and the world.
Geneva [Switzerland], February 16 (ANI): The World Health Organisation (WHO) on Monday (local time) gave emergency use approval (EUA) to two versions of AstraZeneca-Oxford-developed COVID-19 vaccines, allowing these shots to be rolled out globally through COVAX. The vaccines are being produc
New Delhi [India], February 9 (ANI/NewsVoir): The COVID-19 crisis has unleashed a global health and humanitarian crisis like no other claiming lakhs of lives in India. It has pushed healthcare providers to the wall, adversely affecting their operations and service delivery.
Dhaka [Bangladesh], February 7 (ANI): Bangladesh on Sunday launched its nationwide COVID-19 vaccination campaign with the Made in India vaccine by Serum Institute of India, reported Dhaka Tribune.
New Delhi [India], February 3 (ANI): While India has been successful in controlling the Covid-19 pandemic, it also turned out to be a huge opportunity for the country to scale up its healthcare infrastructure, said Director General of the Indian Council of Medical Research (ICMR) Balram Bhar
New Delhi [India], February 2 (ANI): Nepal is very grateful to the Indian government for gifting 1 million doses of COVID-19 vaccine, the country's envoy Nilamber Acharya said on Tuesday, adding that the Himalayan nation is "confident" of getting more doses of the vaccine.
New Delhi [India], February 1 (ANI): Two Indian vaccine manufacturers--Serum Institute of India (SII) and Bharat Biotech--welcomed the allocation of Rs 35,000 crore on Covid-19 vaccination in the Union Budget presented by Finance Minister Nirmala Sitharaman on Monday.
Pune (Maharashtra) [India], January 30 (ANI): A civil court in Pune rejected the injunction application filed on behalf of CUTIS Biotech against Serum Institute of India (SII), claiming trademark "Covishield" of the Covid-19 vaccine, on Saturday.
New Delhi [India], January 30 (ANI): Pharma giant Serum Institute of India (SII), whose Covishield vaccine has already received restricted emergency use approval by the Drugs Controller General of India (DCGI), has now sought permission to start clinical trials of 'COVOVAX', a COVID-19 vacci
New Delhi [India], January 28 (ANI): India's drug regulatory body has received requests from both Pune based Serum Institute of India and Hyderabad-based Bharat Biotech to make necessary changes in the vaccine fact sheet to allow people using blood thinners to get inoculated against Covid-19
Kathmandu [Nepal], January 27 (ANI): Nepal on Wednesday began its nationwide inoculation drive after receiving one million Covishield vaccines, manufactured by the Serum Institute of India (SII), from the Indian government last week.